Search results
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 17 hours agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...
What is the link between lupus and fibromyalgia?
Medical News Today· 6 days agoLupus and fibromyalgia are both chronic, rheumatic conditions that can share similar symptoms. Lupus is long-term autoimmune disease. Fibromyalgia refers...
Fighting fat and inflammation: Scientists develop new compounds
Medical Xpress· 8 hours agoIn a recent study, a team of researchers led by Professor Gen-ichiro Arimura from the Department of...
Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren’s syndrome in...
Nature· 2 days agoPrimary Sjögren’s syndrome (pSS) is a chronic inflammatory autoimmune disease with an unclear pathogenesis, and there is currently no approved drug for ...
Seriously, don't drink the raw milk: Social media doubles down despite bird flu outbreak
Austin American-Statesman via Yahoo News· 1 day agoSome established names, such as famous author and online creator John Green, have also taken to...
What Are the 78 Organs of the Human Body? COVID-19 Organ Damage
MedicineNet.com· 5 days agoPneumonia: COVID-19 can cause lung complications such as pneumonia and, in the most severe cases, acute respiratory distress syndrome (ARDS). Pneumonia causes inflammation ...
Science Shows How Night Shifts Help Bring on Disease
Alaska Superstation· 2 days agoNight shift work can increase a person’s risk of chronic disease, and a new study reveals one possible explanation for this. It appears that just a few...
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update -...
Benzinga· 7 days ago- Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring valacyclovir and celecoxib (IMC-2) expected in the second-half of 2024 - - Conference Call Today at 8:30 a.m.
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days ago$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024 Management to host conference
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Morningstar· 5 days agoTORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
